01:00
About NeoCart
00:41
About NeoCart Procedure
00:49
How is NeoCart Different From Other Cell Based Therapies?
00:53
Experiences with NeoCart
00:57
About Knee Osteoarthritis
01:48
How is NeoCart Different from Microfracture, the Current Standard of Care?
01:05
Experiences With NeoCart
02:18
NeoCart Video V3 shortened PR
01:35
OSU News Segment
04:03
Do you experience knee pain?
02:50
Dr. Kai Mithoefer at Harvard Vanguard Medical Associates talks about a clinical trial
02:56
Doctor Casey D. Taber, M.D. on Great Day San Antonio
02:47
Dr. Brad Tolin on Great Day San Antonio
06:14
Health On The Edge Kim Alexis
10:17
Histogenics Rings Out the NASDAQ (Non-Time Square Version)
10:15
Histogenics Rings Out the NASDAQ (Time Square Version with captions)
06:14
Health On The Edge Kim Alexis
03:18
Dealing with knee pain? You might have another option
02:31
Steadman Hawkins - Denver on NeoCart Clicnical Trial for Knee Pain
01:55
Don't Let Knee Injury Slow You Down; New Clinical Trial NeoCart Phase 3
04:08
New Clinical Trial Alternative To Microfracture, NeoCart Phase 3 Trial.
03:41
Clinical Trial Offers Hope For Knee Pain Suffers
03:44
Clinical Trial Offers Hope For Knee Pain Suffers!
04:07
New Procedure Provides an Alternative to Knee Pain
03:10
Top Sports Medicine Doctor And A New Clinical Trial For Knee Pain Sufferers!
00:32
What I am Missing
X
About
Histogenics (Nasdaq: HSGX) is a leader is personalized restorative cell therapies (RCT) for active living. Our first investigational product candidate, NeoCart® is a proprietary RCT that rebuilds a patient’s own knee cartilage, treating pain at the source and potentially preventing progression to osteoarthritis (OA).
Read our community guidelines: goo.gl/Qtusgh
Tags